Cargando…
Assessment of Cardiac, Vascular, and Pulmonary Pathobiology In Vivo During Acute COVID‐19
BACKGROUND: Acute COVID‐19–related myocardial, pulmonary, and vascular pathology and how these relate to each other remain unclear. To our knowledge, no studies have used complementary imaging techniques, including molecular imaging, to elucidate this. We used multimodality imaging and biochemical s...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683664/ https://www.ncbi.nlm.nih.gov/pubmed/36102258 http://dx.doi.org/10.1161/JAHA.122.026399 |
_version_ | 1784835101980360704 |
---|---|
author | Alam, Shirjel R. Vinayak, Sudhir Shah, Adeel Doolub, Gemina Kimeu, Redemptar Horn, Kevin P. Bowen, Stephen R. Jeilan, Mohamed Lee, Kuan Ken Gachoka, Sylvia Riunga, Felix Adam, Rodney D. Vesselle, Hubert Joshi, Nikhil Obino, Mariah Makhdomi, Khalid Ombati, Kevin Nganga, Edward Gitau, Samuel Chung, Michael H. Shah, Anoop S. V. |
author_facet | Alam, Shirjel R. Vinayak, Sudhir Shah, Adeel Doolub, Gemina Kimeu, Redemptar Horn, Kevin P. Bowen, Stephen R. Jeilan, Mohamed Lee, Kuan Ken Gachoka, Sylvia Riunga, Felix Adam, Rodney D. Vesselle, Hubert Joshi, Nikhil Obino, Mariah Makhdomi, Khalid Ombati, Kevin Nganga, Edward Gitau, Samuel Chung, Michael H. Shah, Anoop S. V. |
author_sort | Alam, Shirjel R. |
collection | PubMed |
description | BACKGROUND: Acute COVID‐19–related myocardial, pulmonary, and vascular pathology and how these relate to each other remain unclear. To our knowledge, no studies have used complementary imaging techniques, including molecular imaging, to elucidate this. We used multimodality imaging and biochemical sampling in vivo to identify the pathobiology of acute COVID‐19. Specifically, we investigated the presence of myocardial inflammation and its association with coronary artery disease, systemic vasculitis, and pneumonitis. METHODS AND RESULTS: Consecutive patients presenting with acute COVID‐19 were prospectively recruited during hospital admission in this cross‐sectional study. Imaging involved computed tomography coronary angiography (identified coronary disease), cardiac 2‐deoxy‐2‐[fluorine‐18]fluoro‐D‐glucose positron emission tomography/computed tomography (identified vascular, cardiac, and pulmonary inflammatory cell infiltration), and cardiac magnetic resonance (identified myocardial disease) alongside biomarker sampling. Of 33 patients (median age 51 years, 94% men), 24 (73%) had respiratory symptoms, with the remainder having nonspecific viral symptoms. A total of 9 patients (35%, n=9/25) had cardiac magnetic resonance–defined myocarditis. Of these patients, 53% (n=5/8) had myocardial inflammatory cell infiltration. A total of 2 patients (5%) had elevated troponin levels. Cardiac troponin concentrations were not significantly higher in patients with and without myocarditis (8.4 ng/L [interquartile range, IQR: 4.0–55.3] versus 3.5 ng/L [IQR: 2.5–5.5]; P=0.07) or myocardial cell infiltration (4.4 ng/L [IQR: 3.4–8.3] versus 3.5 ng/L [IQR: 2.8–7.2]; P=0.89). No patients had obstructive coronary artery disease or vasculitis. Pulmonary inflammation and consolidation (percentage of total lung volume) was 17% (IQR: 5%–31%) and 11% (IQR: 7%–18%), respectively. Neither were associated with the presence of myocarditis. CONCLUSIONS: Myocarditis was present in a third patients with acute COVID‐19, and the majority had inflammatory cell infiltration. Pneumonitis was ubiquitous, but this inflammation was not associated with myocarditis. The mechanism of cardiac pathology is nonischemic and not attributable to a vasculitic process. REGISTRATION: URL: https://www.isrctn.com; Unique identifier: ISRCTN12154994. |
format | Online Article Text |
id | pubmed-9683664 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96836642022-11-25 Assessment of Cardiac, Vascular, and Pulmonary Pathobiology In Vivo During Acute COVID‐19 Alam, Shirjel R. Vinayak, Sudhir Shah, Adeel Doolub, Gemina Kimeu, Redemptar Horn, Kevin P. Bowen, Stephen R. Jeilan, Mohamed Lee, Kuan Ken Gachoka, Sylvia Riunga, Felix Adam, Rodney D. Vesselle, Hubert Joshi, Nikhil Obino, Mariah Makhdomi, Khalid Ombati, Kevin Nganga, Edward Gitau, Samuel Chung, Michael H. Shah, Anoop S. V. J Am Heart Assoc Original Research BACKGROUND: Acute COVID‐19–related myocardial, pulmonary, and vascular pathology and how these relate to each other remain unclear. To our knowledge, no studies have used complementary imaging techniques, including molecular imaging, to elucidate this. We used multimodality imaging and biochemical sampling in vivo to identify the pathobiology of acute COVID‐19. Specifically, we investigated the presence of myocardial inflammation and its association with coronary artery disease, systemic vasculitis, and pneumonitis. METHODS AND RESULTS: Consecutive patients presenting with acute COVID‐19 were prospectively recruited during hospital admission in this cross‐sectional study. Imaging involved computed tomography coronary angiography (identified coronary disease), cardiac 2‐deoxy‐2‐[fluorine‐18]fluoro‐D‐glucose positron emission tomography/computed tomography (identified vascular, cardiac, and pulmonary inflammatory cell infiltration), and cardiac magnetic resonance (identified myocardial disease) alongside biomarker sampling. Of 33 patients (median age 51 years, 94% men), 24 (73%) had respiratory symptoms, with the remainder having nonspecific viral symptoms. A total of 9 patients (35%, n=9/25) had cardiac magnetic resonance–defined myocarditis. Of these patients, 53% (n=5/8) had myocardial inflammatory cell infiltration. A total of 2 patients (5%) had elevated troponin levels. Cardiac troponin concentrations were not significantly higher in patients with and without myocarditis (8.4 ng/L [interquartile range, IQR: 4.0–55.3] versus 3.5 ng/L [IQR: 2.5–5.5]; P=0.07) or myocardial cell infiltration (4.4 ng/L [IQR: 3.4–8.3] versus 3.5 ng/L [IQR: 2.8–7.2]; P=0.89). No patients had obstructive coronary artery disease or vasculitis. Pulmonary inflammation and consolidation (percentage of total lung volume) was 17% (IQR: 5%–31%) and 11% (IQR: 7%–18%), respectively. Neither were associated with the presence of myocarditis. CONCLUSIONS: Myocarditis was present in a third patients with acute COVID‐19, and the majority had inflammatory cell infiltration. Pneumonitis was ubiquitous, but this inflammation was not associated with myocarditis. The mechanism of cardiac pathology is nonischemic and not attributable to a vasculitic process. REGISTRATION: URL: https://www.isrctn.com; Unique identifier: ISRCTN12154994. John Wiley and Sons Inc. 2022-09-14 /pmc/articles/PMC9683664/ /pubmed/36102258 http://dx.doi.org/10.1161/JAHA.122.026399 Text en © 2022 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Research Alam, Shirjel R. Vinayak, Sudhir Shah, Adeel Doolub, Gemina Kimeu, Redemptar Horn, Kevin P. Bowen, Stephen R. Jeilan, Mohamed Lee, Kuan Ken Gachoka, Sylvia Riunga, Felix Adam, Rodney D. Vesselle, Hubert Joshi, Nikhil Obino, Mariah Makhdomi, Khalid Ombati, Kevin Nganga, Edward Gitau, Samuel Chung, Michael H. Shah, Anoop S. V. Assessment of Cardiac, Vascular, and Pulmonary Pathobiology In Vivo During Acute COVID‐19 |
title | Assessment of Cardiac, Vascular, and Pulmonary Pathobiology In Vivo During Acute COVID‐19 |
title_full | Assessment of Cardiac, Vascular, and Pulmonary Pathobiology In Vivo During Acute COVID‐19 |
title_fullStr | Assessment of Cardiac, Vascular, and Pulmonary Pathobiology In Vivo During Acute COVID‐19 |
title_full_unstemmed | Assessment of Cardiac, Vascular, and Pulmonary Pathobiology In Vivo During Acute COVID‐19 |
title_short | Assessment of Cardiac, Vascular, and Pulmonary Pathobiology In Vivo During Acute COVID‐19 |
title_sort | assessment of cardiac, vascular, and pulmonary pathobiology in vivo during acute covid‐19 |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683664/ https://www.ncbi.nlm.nih.gov/pubmed/36102258 http://dx.doi.org/10.1161/JAHA.122.026399 |
work_keys_str_mv | AT alamshirjelr assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19 AT vinayaksudhir assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19 AT shahadeel assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19 AT doolubgemina assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19 AT kimeuredemptar assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19 AT hornkevinp assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19 AT bowenstephenr assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19 AT jeilanmohamed assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19 AT leekuanken assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19 AT gachokasylvia assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19 AT riungafelix assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19 AT adamrodneyd assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19 AT vessellehubert assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19 AT joshinikhil assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19 AT obinomariah assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19 AT makhdomikhalid assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19 AT ombatikevin assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19 AT ngangaedward assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19 AT gitausamuel assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19 AT chungmichaelh assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19 AT shahanoopsv assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19 |